Introduction:Basic information about CAS 199739-10-1|Paliperidone Palmitate, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Paliperidone Palmitate |
|---|
| CAS Number | 199739-10-1 | Molecular Weight | 664.893 |
|---|
| Density | 1.2±0.1 g/cm3 | Boiling Point | 736.3±70.0 °C at 760 mmHg |
|---|
| Molecular Formula | C39H57FN4O4 | Melting Point | / |
|---|
| MSDS | / | Flash Point | 399.1±35.7 °C |
|---|
Names
| Name | [3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-4-oxo-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-9-yl] hexadecanoate |
|---|
| Synonym | More Synonyms |
|---|
Paliperidone Palmitate BiologicalActivity
| Description | Paliperidone palmitate (9-Hydroxyrisperidone palmitate), an atypical long-acting antipsychotic agent, is an ester prodrug of Paliperidone. Paliperidone is a dopamine antagonist and 5-HT2A antagonist of the atypical antipsychotic class. Paliperidone palmitate shows efficacy against schizophrenia[1]. |
|---|
| Related Catalog | Signaling Pathways >>GPCR/G Protein >>Dopamine ReceptorSignaling Pathways >>Neuronal Signaling >>Dopamine ReceptorResearch Areas >>Neurological DiseaseSignaling Pathways >>GPCR/G Protein >>5-HT ReceptorSignaling Pathways >>Neuronal Signaling >>5-HT Receptor |
|---|
| Target | 5-HT2A Receptor D2 Receptor |
|---|
| References | [1]. Kwon JS, et al. Satisfaction of immediate or delayed switch to paliperidone palmitate in patients unsatisfied with current oral atypical antipsychotics. Int Clin Psychopharmacol. 2015;30(6):320-328. |
|---|
Chemical & Physical Properties
| Density | 1.2±0.1 g/cm3 |
|---|
| Boiling Point | 736.3±70.0 °C at 760 mmHg |
|---|
| Molecular Formula | C39H57FN4O4 |
|---|
| Molecular Weight | 664.893 |
|---|
| Flash Point | 399.1±35.7 °C |
|---|
| Exact Mass | 664.436401 |
|---|
| PSA | 90.46000 |
|---|
| LogP | 9.85 |
|---|
| Vapour Pressure | 0.0±2.4 mmHg at 25°C |
|---|
| Index of Refraction | 1.590 |
|---|
| InChIKey | VOMKSBFLAZZBOW-UHFFFAOYSA-N |
|---|
| SMILES | CCCCCCCCCCCCCCCC(=O)OC1CCCn2c1nc(C)c(CCN1CCC(c3noc4cc(F)ccc34)CC1)c2=O |
|---|
| Storage condition | -20℃ |
|---|
Synonyms
| 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido-[1,2-a]pyrimidin-4-one palmitate ester |
| 9-Hydroxyrisperidone palmitate |
| Xeplion |
| PALPERIDONE PALMITATE |
| UNII-R8P8USM8FR |
| Paliperidone Palmitate |
| Invega Sustenna |
| Paliperidone Palmitate [USAN] |
| 3-[2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)-1-piperidyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one palmitate ester |
| Hexadecanoic acid, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl ester |
| 3-{2-[4-(6-Fluoro-1,2-benzoxazol-3-yl)-1-piperidinyl]ethyl}-2-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-9-yl palmitate |